InMed Pharmaceuticals (INM) Cash & Current Investments (2020 - 2026)
InMed Pharmaceuticals (INM) posted quarterly Cash & Current Investments of $5.2 million for Q1 2026, up 10.57% year-over-year from $4.7 million in Q1 2025, and down 25.57% quarter-over-quarter from $7.0 million in Q4 2025.
InMed Pharmaceuticals (INM) Cash & Current Investments (2020 - 2026) Analysis & Trends
InMed Pharmaceuticals' Cash & Current Investments history runs 7 years deep, the most recent figure standing at $5.2 million for Q1 2026.
- In Q1 2026, Cash & Current Investments rose 10.57% year-over-year to $5.2 million; the TTM figure through Mar 2026 stood at $5.2 million (up 10.57% YoY), while the FY2025 annual figure was $10.8 million, up 63.07% from the prior year.
- Cash & Current Investments for Q1 2026 stood at $5.2 million, down from $7.0 million in the prior quarter.
- The five-year high for Cash & Current Investments was $11.5 million in Q4 2022, with the low at $1.3 million in Q3 2024.
- The 5-year median for Cash & Current Investments is $6.6 million (2024), against an average of $6.8 million.
- The sharpest annual moves came in 2023 and 2025: Cash & Current Investments slumped 88.23% in 2023, then jumped 632.31% in 2025.
- InMed Pharmaceuticals' Cash & Current Investments stood at $11.5 million in 2022, then plunged by 88.23% to $1.4 million in 2023, then surged by 224.37% to $4.4 million in 2024, then surged by 60.54% to $7.0 million in 2025, then dropped by 25.57% to $5.2 million in 2026.
- Business Quant data shows INM's Cash & Current Investments at $5.2 million in Q1 2026, $7.0 million in Q4 2025, and $9.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - | 963.33 Mn |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn | 3.66 Bn |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn | 1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | 5.80 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 2.66 Bn |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn | 886.50 Mn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 389.80 Mn |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | 530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | 164.00 Mn |
| 10 | InMed Pharmaceuticals | 6.48 Mn | 1.24 Mn | - | 5.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.24 Mn |
| Dec 31, 2025 | 7.04 Mn |
| Sep 30, 2025 | 9.37 Mn |
| Jun 30, 2025 | 10.79 Mn |
| Mar 31, 2025 | 4.74 Mn |
| Dec 31, 2024 | 4.39 Mn |
| Sep 30, 2024 | 1.28 Mn |
| Jun 30, 2024 | 6.61 Mn |
| Mar 31, 2024 | 6.62 Mn |
| Dec 31, 2023 | 1.35 Mn |
| Sep 30, 2023 | 6.78 Mn |
| Jun 30, 2023 | 8.96 Mn |
| Mar 31, 2023 | 9.64 Mn |
| Dec 31, 2022 | 11.50 Mn |
| Sep 30, 2022 | 9.39 Mn |
| Jun 30, 2022 | 6.22 Mn |
| Mar 31, 2022 | 5.95 Mn |
| Dec 31, 2021 | 11.35 Mn |
| Sep 30, 2021 | 15.35 Mn |
| Jun 30, 2021 | 7.41 Mn |